Skip to main content

Remote Job Finders (RJF)

Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy

As Trump has pressured drugmakers to lower the cost of medicines in the U.S., the pharma industry has coalesced behind a message of rebalancing what nations pay to better reflect the innovation and value of drugmaking.

Vedanta Downsizes by 20% After Phase II Stumble in Ulcerative Colitis

Vedanta is parting ways with 23 employees, or approximately 20% of its headcount, after Phase II data for microbiome therapy VE202 failed to demonstrate significant response rates in patients with ulcerative colitis.
Scroll to top